Lung Cancer, Non-small Cell
Oncology
1
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
AstraZenecaTagrisso
City TherapeuticsGenomic profiles detection
Clinical Trials (2)
Total enrollment: 40 patients across 2 trials
Neo-adjuvant Trial With AZD9291 in EGFRm+ Stage IIIA/B NSCLC
Start: Nov 2018Est. completion: Dec 202240 patients
Phase 2Unknown
Exploring the Mechanism of Primary Resistance to Third-generation EGFR-TKIs as First-line Treatment in EGFR-positive Advanced NSCLC (PRECISE Study)
Start: Sep 2021Est. completion: Dec 2026
N/ARecruiting
Related Jobs in Oncology
Senior Research Associate, Immuno-Oncology
SystImmune
8m ago
$60K - $85K/yr
Research Associate I/II, Immuno-Oncology
SystImmune
8m ago
Office Administrator
SystImmune
8m ago
$60K - $80K/yr
Scientist/Sr Scientist
TwoStep Therapeutics
San Carlos
18m ago
Working Student Office Management Support (m/f/d)
Mindpeak
Hamburg
22m ago
Senior Medical Project Manager (m/f/d)
Mindpeak
Hamburg
22m ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 40 patients
2 companies competing in this space